From the Editor-in-Chief

Obesity and increased cancer risk have been linked. Could new drugs promising to reduce weight also lower the risk of cancer?

by William G. Nelson, MD, PhD

Researchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.

by Eric Fitzsimmons

Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.

by Sandra Gordon

New research fuels progress in cancer survival, prevention and side effect management.

Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.

by Thomas Celona

What people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.

by Kevin McLaughlin

Forward Look

Tests currently in development seek to offer greater accuracy and reach more people.

by Eric Fitzsimmons

AACR highlights team research that led to Lynch syndrome testing for all people with endometrial cancer in the U.K.

by Marci A. Landsmann

Phase I clinical trial finds adding a radiosensitizer may improve radiation’s ability to kill this fast-growing brain cancer.

by Thomas Celona

As more people diagnosed with and treated for cancer live years beyond treatment, researchers look for ways to improve quality of life.

by Kevin McLaughlin